Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol tafla 200 mg
novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol retard forðatafla 200 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol retard forðatafla 400 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 400 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
omnic hart hylki með breyttan losunarhraða 0,4 mg
astellas pharma a/s* - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg